Previous studies have shown that a vaccine derived from ApoB-100 exerts a therapeutic effect by inhibiting atherosclerosis, and a P210 vaccine can reduce the progression of atherosclerosis in ApoE−/− mice by approximately 40% [18, 19]. The gene discussed is APOE; the disease is atherosclerosis.